Gut Signature for Treatment-Resistant Schizophrenia?
Adults with resistant schizophrenia have significant gut microbiome differences vs their counterparts who respond to treatment, a new finding that may be driven by clozapine treatment.
Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adults with resistant schizophrenia have significant gut microbiome differences vs their counterparts who respond to treatment, a new finding that may be driven by clozapine treatment.
In patients with SUD, even slight reductions in drug use are linked to better outcomes, suggesting abstinence should not be the only goal of treatment, a new analysis showed.
More than 2 years after its controversial accelerated FDA approval, Biogen says it will halt development and commercialization of aducanumab and focus on lecanemab.
Once-weekly insulin icodec reduced A1c levels the same or better than once-daily glargine and degludec.
Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up to 2 years of follow-up.